Nathan Reticker-Flynn, PhD

Nathan Reticker-Flynn is a tumor immunologist working at the interfaces of immunological tolerance, cancer metastasis, tumor evolution, adaptive immunity, and immunotherapy. He is an Assistant Professor at Stanford University in the Department of Otolaryngology and a member of the Stanford Cancer Institute. He received his PhD from the Massachusetts Institute of Technology while working in the lab of Dr. Sangeeta Bhatia and performed his postdoctoral studies with Dr. Edgar Engleman at Stanford University. His discoveries include the revelation that effective immunotherapies require systemic extratumoral activation of anti-tumor immunity and that lymph node metastases serve to reeducate adaptive immune responses in a manner that promotes distant metastasis. His lab currently investigates mechanisms of immune tolerance and regulatory T cells in cancer metastasis and autoimmune diseases, employs systems approach to model tumor-immune coevolution, and develops new immunotherapies that target tolerance programs within lymph nodes.